The World Health Organization (WHO) has issued a compelling global appeal for nations to significantly amplify their efforts in newborn screening for congenital conditions, underscoring its pivotal role in preventing premature mortality and mitigating lifelong disabilities among millions of infants. This urgent call to action is detailed in a new publication, "Strengthening capacity for newborn screening, diagnosis and management of birth defects," which positions expanded screening as a crucial accelerator for progress in child survival metrics worldwide. The document serves as a comprehensive guide, particularly for health ministries in low- and middle-income countries (LMICs), to establish and scale up effective screening programs tailored to their specific national contexts.
Early identification and subsequent intervention represent a critical window of opportunity that can dramatically alter the life trajectory for children born with a range of conditions. For instance, congenital hypothyroidism, if detected and managed promptly, can prevent severe intellectual disability. Similarly, early diagnosis of sickle-cell disease allows for life-saving prophylactic treatments and comprehensive care, significantly improving quality of life and longevity. Timely detection of hearing impairment facilitates early auditory rehabilitation, fostering speech and language development crucial for cognitive and social integration. A spectrum of metabolic disorders also falls into this category, where dietary or therapeutic adjustments initiated in infancy can avert catastrophic health crises and developmental delays. Despite the proven efficacy of these interventions, a staggering number of children globally continue to be diagnosed too late, or tragically, never receive any treatment at all, perpetuating cycles of preventable suffering and disability.
The statistical burden of congenital anomalies paints a stark picture of a pressing global health challenge. Annually, an estimated eight million babies are born with some form of birth defect. These conditions now account for nearly 8% of all deaths among children under the age of five, signifying a substantial and growing contribution to child mortality. The disproportionate impact is particularly pronounced in LMICs, where approximately 90% of children born with severe birth defects reside. These regions frequently grapple with limited access to the essential infrastructure, trained personnel, and financial resources required for comprehensive screening, accurate diagnosis, and sustained therapeutic management. This stark disparity highlights a profound inequity in global child health, where a child’s birthplace often dictates their chance at a healthy future.
Dr. Tedros Adhanom Ghebreyesus, the Director-General of the WHO, articulated the organization’s conviction, stating, "No child should be deprived of the opportunity for a healthy life simply because a congenital condition went undetected early on." He further emphasized the demonstrable success of various nations in implementing newborn screening for a single or multiple conditions, proving its capacity to save lives, avert disabilities, and empower newborns to reach their full potential. The current global landscape reveals a significant chasm between countries; while some nations boast universal screening for over 50 conditions, others lack the capacity to screen for any. The WHO strongly advocates for every country to initiate newborn screening, recommending a phased approach that begins with one priority condition and gradually expands as national health system capacities mature.
The increasing proportion of under-five deaths attributable to birth defects in many regions reflects a complex epidemiological shift. Between 2000 and 2023, the percentage of under-five fatalities linked to congenital anomalies surged from 1% to 4% in Sub-Saharan Africa and from 3% to 11% in South Asia. This concerning trend, however, is not solely indicative of an absolute rise in birth defects. Rather, it also represents a significant achievement in global public health: a marked reduction in deaths from infectious diseases and other historically prevalent, preventable causes. As societies successfully combat maladies like pneumonia, diarrhea, and malaria through improved vaccinations, sanitation, and access to basic healthcare, congenital conditions emerge more prominently as a leading cause of child mortality, demanding renewed focus and integrated strategies. This re-prioritization aligns with the broader objectives of the Sustainable Development Goals, particularly Goal 3.2, which aims to end preventable deaths of newborns and children under 5 years of age.
The WHO’s report serves as a vital strategic resource, guiding health ministries, particularly in LMICs, through the complex process of prioritizing conditions for newborn screening. This prioritization process involves a careful assessment of factors such as the prevalence of specific conditions within a population, the availability of effective and affordable diagnostic tools, the existence of viable treatment options, and the overall capacity of the national health system to support comprehensive screening, follow-up, and long-term care. The report draws on a global consultation that convened a diverse array of stakeholders, including government representatives, technical experts, clinicians, researchers, professional associations, civil society organizations, and families personally affected by birth defects, ensuring a holistic and evidence-based approach to strengthening these critical health services.
Several countries across different continents have already successfully integrated large-scale newborn screening programs into their routine health services, providing invaluable blueprints for others.
In Argentina, proactive policy measures and sustained investment have propelled newborn screening coverage to nearly universal levels, demonstrating a strong national commitment to early child health.
Brazil has systematically expanded its nationwide screening efforts, now encompassing multiple life-threatening conditions. This expansion is often linked to its robust public health system, which aims to provide comprehensive care from birth.
Egypt has innovated by integrating universal newborn screening for hearing impairment and congenital hypothyroidism directly into its primary healthcare services through a structured "newborn care pathway." This integration ensures accessibility and streamlines the screening process for a wide population.
India, through its extensive national program, has screened over 28 million children in just three years, a monumental achievement given its vast population. This initiative has successfully identified approximately 900,000 children with birth defects, effectively connecting them with crucial diagnostic services, timely treatment, and ongoing support, including long-term care and rehabilitation provided through a network of district early intervention centers. These centers offer a multidisciplinary approach, vital for complex conditions.
The Philippines exemplifies a remarkable journey from a pilot project in a mere 24 hospitals to a comprehensive national program. It now screens newborns for 29 distinct conditions across more than 7,000 facilities nationwide. A key enabler for this success is the establishment of clear diagnostic and management pathways for all screened conditions within the national health system. Furthermore, newborn screening is both mandated by law and covered by national health insurance, eliminating financial barriers for families.
Sri Lanka has seamlessly integrated newborn screening into its routine maternity and pediatric care. The program currently screens for visible birth defects and congenital hypothyroidism, achieving approximately 80% coverage for the latter, showcasing the benefits of embedding these services within existing healthcare structures.
In Uganda, a state-led program specifically targeting sickle-cell disease operates in high-burden areas. This focused approach enables early identification of affected infants, providing them with life-saving treatments and essential long-term follow-up care, significantly improving their prognosis in a region where the genetic disorder is particularly prevalent.
The WHO’s overarching recommendation is for governments to embed newborn screening, comprehensive diagnosis, and effective treatment pathways firmly within their routine health services and universal health coverage programs. This integration should be strategically phased, commencing with conditions that represent significant country-specific priorities and for which feasible detection and management strategies are already available or can be rapidly developed within the existing health infrastructure. Implementing these programs requires not only political will but also sustained investment in laboratory capacity, training of healthcare professionals, robust data management systems, and effective communication strategies to raise parental awareness and ensure compliance with follow-up care. By fostering these essential components, countries can move closer to ensuring that every child, regardless of their circumstances, has the fundamental right to an early diagnosis and the best possible start in life, thereby unlocking their full developmental potential and contributing to healthier, more equitable societies.
About the Author
